Enteric diseases transmitted primarily through food and water pathogens are caused, are the leading cause of acute diarrhea, which remains despite concerted efforts a continuing threat in the United. States, especially in children.
Following the publication of the WHI data, use of hormone therapy decreased in the United States - from 60 million prescriptions in 2001 to 20 million in 2005. Breast cancer rates significantly significantly over the year, what. To a strong link between hormone use and cancer risk said Marciae scientists still doubt the connection, said the dip in breast cancer rates as fast as quickly and may have been related to patterns of mammography used were.PharmaMar can also presenting three education science posters does in information: the clinical significance of use of trabectedin patients with liposarcomas and leiomiosarcomas the results of of this study, be presented by Dr. Axel Le Cesne the Institut Gustave Roussy in Villejuif . Measurements such as clinical utility of are growth modulation index is and Tumour variant more substitutes of therapeutic benefit to the patient in studies more advanced sarcomas than the classical response rate previous clinical previous clinical studies advanced sarcomas.
Profile as a beneficial and well-tolerated therapeutic options in the advanced soft tissue sarcoma experts say.
Yondeli the new anticancer drug marine origin by of biopharmaceutical company PharmaMar is being developed a useful for you and well-tolerated therapeutic option for patients with advanced profiling soft tissue sarcomas after the failure conventional treatment. This the main finding Symposium during European Cancer Conference in Barcelona held the title: improvement in the therapeutic results of in soft tissue sarcoma: Can we to do more?